Hargreaves Lansdown

Abingdon Health to launch two Boots-branded self-tests

Wed 20 March 2024 11:00 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Lateral flow test specialist Abingdon Health announced a partnership with Crest Medical on Wednesday, to introduce Boots' own-brand rapid self-tests across the UK and online.

The AIM-traded firm said the initial launch would include two products, iron and vitamin D deficiency self-tests, under the Boots own-brand range.

Abingdon sid the tests were scheduled for availability in stores and online at Boots.com from the spring.

"We are delighted to announce the launch of the Boots own-brand iron and vitamin D deficiency self-tests in conjunction with our partner Crest Medical," said chief executive officer Chris Yates.

"As lateral flow experts we're proud to offer a comprehensive private label service to retailers covering a broad range of self-tests, including innovative exclusive products from Abingdon's CDMO customers.

"We take immense pride in the quality of our service and ensure a seamless supply of innovative lateral flow self-tests to ensure our partners requirements are met."

At 1041 GMT, shares in Abingdon Health were up 17.65% at 10p.

Reporting by Josh White for Sharecast.com.

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.


    More AIM news from ShareCast

    No results were found